RIMESSI, Paola
 Distribuzione geografica
Continente #
NA - Nord America 6.110
AS - Asia 3.376
EU - Europa 2.274
SA - Sud America 485
AF - Africa 83
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 1
Totale 12.347
Nazione #
US - Stati Uniti d'America 5.956
SG - Singapore 1.369
CN - Cina 821
DE - Germania 513
VN - Vietnam 400
IT - Italia 388
BR - Brasile 380
UA - Ucraina 273
PL - Polonia 240
GB - Regno Unito 231
HK - Hong Kong 227
FI - Finlandia 175
TR - Turchia 171
SE - Svezia 106
IN - India 90
FR - Francia 86
CA - Canada 82
RU - Federazione Russa 78
JP - Giappone 77
MX - Messico 53
ID - Indonesia 42
AR - Argentina 40
NL - Olanda 36
ZA - Sudafrica 32
IQ - Iraq 31
BD - Bangladesh 29
ES - Italia 27
LT - Lituania 20
AT - Austria 19
BE - Belgio 18
VE - Venezuela 18
CO - Colombia 17
CZ - Repubblica Ceca 16
PH - Filippine 16
PK - Pakistan 16
AU - Australia 14
TN - Tunisia 13
UZ - Uzbekistan 13
SA - Arabia Saudita 12
CH - Svizzera 9
CL - Cile 9
MA - Marocco 9
EC - Ecuador 8
EG - Egitto 8
MY - Malesia 8
DZ - Algeria 7
IE - Irlanda 7
IR - Iran 7
JO - Giordania 7
PY - Paraguay 7
AE - Emirati Arabi Uniti 6
NP - Nepal 6
KE - Kenya 5
LB - Libano 5
CR - Costa Rica 4
RO - Romania 4
AZ - Azerbaigian 3
BB - Barbados 3
BO - Bolivia 3
HU - Ungheria 3
JM - Giamaica 3
KZ - Kazakistan 3
NZ - Nuova Zelanda 3
PS - Palestinian Territory 3
PT - Portogallo 3
SI - Slovenia 3
TW - Taiwan 3
AO - Angola 2
BG - Bulgaria 2
BY - Bielorussia 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
GR - Grecia 2
MK - Macedonia 2
OM - Oman 2
PA - Panama 2
QA - Qatar 2
RS - Serbia 2
UY - Uruguay 2
BH - Bahrain 1
CD - Congo 1
CM - Camerun 1
EE - Estonia 1
ET - Etiopia 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
IL - Israele 1
KG - Kirghizistan 1
LI - Liechtenstein 1
LK - Sri Lanka 1
LV - Lettonia 1
MD - Moldavia 1
ME - Montenegro 1
ML - Mali 1
MR - Mauritania 1
NI - Nicaragua 1
NO - Norvegia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
Totale 12.339
Città #
Singapore 846
Ashburn 715
Fairfield 460
San Jose 438
Woodbridge 437
Chandler 386
Houston 350
Beijing 320
Jacksonville 272
Munich 264
Santa Clara 238
Warsaw 235
Ann Arbor 231
Hong Kong 221
Seattle 175
Wilmington 153
Los Angeles 138
Cambridge 134
Ho Chi Minh City 123
New York 117
Izmir 92
Nanjing 81
Hanoi 78
Helsinki 78
Tokyo 74
Dallas 69
Princeton 68
Milan 57
Shanghai 54
Lauterbourg 53
São Paulo 51
London 50
Buffalo 49
Ferrara 49
Council Bluffs 44
San Diego 44
Boardman 41
Orem 37
Turku 37
Mexico City 33
Bremen 32
Montreal 31
Tianjin 30
Da Nang 29
Jakarta 29
Bologna 28
Brooklyn 27
Dearborn 27
Hefei 27
Falkenstein 26
Denver 24
Stockholm 24
Chicago 22
Johannesburg 22
San Mateo 22
Atlanta 21
Frankfurt am Main 21
The Dalles 21
Poplar 20
Toronto 20
Chennai 19
Brussels 18
Falls Church 18
Haiphong 18
Changsha 17
Hebei 15
Jiaxing 15
Nanchang 15
Phoenix 14
Washington 14
Mumbai 13
Shenyang 13
Amsterdam 12
Rio de Janeiro 12
Tashkent 12
Brasília 11
Brno 11
Guangzhou 11
Moscow 11
Naples 11
San Francisco 11
Auburn Hills 10
Baghdad 10
Norwalk 10
Nuremberg 10
Reggio Emilia 10
Rome 10
Boston 9
Istanbul 9
Ningbo 9
Ottawa 9
Philadelphia 9
Thái Bình 9
Des Moines 8
Haikou 8
Hangzhou 8
Hải Dương 8
Jinan 8
Kunming 8
Mountain View 8
Totale 8.356
Nome #
HIV-1 Tat protein modulates the generation of cytotoxic T cell epitopes by modifying proteasome composition and enzymatic activity 399
Un'ipotonia sospetta 372
Persistent Dystrophin Protein Restoration 90 Days after a Course of Intraperitoneally Administered Naked 2′OMePS AON and ZM2 NP-AON Complexes in mdx Mice 305
Cationic PMMA nanoparticles bind and deliver antisense oligoribonucleotides allowing restoration of dystrophin expression in the mdx mouse 277
A Family with γ-Thalassemia and High Hb A2 Levels 270
A novel custom high density-comparative genomic hybridization array detects common rearrangements as well as deep intronic mutations in dystrophinopathies 260
A BK virus episomal vector for constitutive high expression of exogenous cDNAs in human cells 248
GENETIC, CLINICAL AND NEUROPATHOLOGICAL INSIGHTS INTO PATIENTS WITH ASCERTAINED DIAGNOSIS OF HUNTINGTON DISEASE 246
G.P.12.06 A comprehensive molecular characterisation of dystrophinopathies 246
Intronic breakpoint definition and transcription analysis in DMD/BMD patients with deletion/duplication at the 5′ mutation hot spot of the dystrophin gene 240
Exon skipping-mediated dystrophin reading frame restoration for small mutations 238
Antisense modulation of both exonic and intronic splicing motifs induces skipping of a DMD pseudo-exon responsible for X-linked dilated cardiomyopathy 229
Transthyretin RNA profiling in livers from transplanted patients affected by familial amyloidotic polyneuropathy, and identification of a dual transcription start point 223
International-DMD (IDMD): a PTC Therapeutics-supported diagnostic project to widely identify Dystrophin mutations by NGS technologies 221
Biodistribution and Molecular Studies on Orally Administered Nanoparticle-AON Complexes Encapsulated with Alginate Aiming at Inducing Dystrophin Rescue in mdx Mice 219
Commercial kit-based diagnosis is not enough for prenatal testing of beta-thalassemia: pitfalls in diagnostic mutation analysis raises the need for reference laboratories 210
Disease profile and differential diagnosis of hereditary transthyretin-related amyloidosis with exclusively cardiac phenotype: an Italian perspective 209
Identification of cytotoxic T lymphocyte epitopes of human herpesvirus 8 209
Transcriptional behavior of DMD gene duplications in DMD/BMD males 205
The DMD Locus Harbours Multiple Long Non-Coding RNAs Which Orchestrate and Control Transcription of Muscle Dystrophin mRNA Isoforms 205
Exon Skipping Quantification by Real-Time PCR 205
Antisense oligonucleotides conjugated with lipophilic compounds: synthesis and in vitro evaluation of exon skipping in duchenne muscular dystrophy 201
Dystrophin levels as low as 30% are sufficient to avoid muscular dystrophy in the human 200
Characterization of a 4-Mb region at chromosome 6q21 harboring a replicative senescence gene 199
Antisense oligonucleotides capable of inducing exon skipping in dystrophin gene and their use in treatment of duchenne muscular dystrophy 195
High expression of exogenous cDNAs directed by HIV-1 long terminal repeat in human cells constitutively producing HIV-1 tat and adenovirus E1A/E1B 185
RNA-seq in DMD urinary stem cells recognized muscle-related transcription signatures and addressed the identification of atypical mutations by whole-genome sequencing 183
T.P.2.07 The systemic administration of a low dose of 2OMePS-AON combined with novel cationic polymethylmethacrylate nanoparticles induces the rescue of dystrophin expression in the mdx murine model 182
Can paranasal sinus computed tomography screen for cystic fibrosis heterozygotes? 182
DMD gene molecular genetic characterization in Eastern Europe and non European countries 179
Characterization of BKV variants rescued from human tumors and tumor cell lines 178
Genomic definition of a pure intronic dystrophin deletion responsible for an XLDC splicing mutation: In vitro mimicking and antisense modulation of the splicing abnormality 175
Systemic Expression of HIV-1 tat Gene in Transgenic Mice Induces Endothelial Proliferation and Ibmors of Different Histotypes 175
Preclinical PK and PD studies on 2′-O-methyl-phosphorothioate RNA antisense oligonucleotides in the mdx mouse model 175
In vivo study of an aberrant dystrophin exon inclusion in X-linked dilated cardiomyopathy 171
Farmacogenetica dei taxani nel trattamento del carcinoma mammario: possibile ruolo nell’identificazione del rischio di tossicità. 164
Tempo and mode of evolution of a primate-specific retrotransposon belonging to the LINE 1 family. 162
Transformation of human cells by recombinant DNA molecules containing BK virus early region and the human activated c-Hras or c-myc oncogenes 160
Prenatal diagnosis of Duchenne muscular dystrophy by comparative genomic hybridization 159
Carpal tunnel syndrome in cardiac amyloidosis: implications for early diagnosis and prognostic role across the spectrum of aetiologies 159
Phenotypic and genotypic heterogeneity in transthyretin-related cardiac amyloidosis: towards tailoring of therapeutic strategies? 158
Uso di modelli di trasformazione virale nello studio dei geni oncosoppressori tramite trasferimento monocromosomico. 158
La consulenza oncogenetica per il carcinoma mammario ed ovarico con ricorrenza familiare come parte di un Percorso integrato multidisciplinare. 157
Workload measurement for molecular genetics laboratory: A survey study 155
The Genetic Landscape of Dystrophin Mutations in Italy: A Nationwide Study 154
Localizzazione preliminare di tumor suppressor genes mediante chromosome transfer. 148
Tumorigenicity and anchorage-independent growth suppression of BK virus transformed mouse cells by human chromosome 11 148
G.P.3.02 In vivo biodistribution of non-viral systems for oligoribonucleotides delivery 143
Generation of a human induced pluripotent stem cell line (UNIFEi001-A) from a patient with Spinocerebellar ataxia type 1 (SCA1) 142
ncRNAs originating from the dystrophin gene as biomarker for assessing antisense therapy 139
Genetic analysis of a 6q21 region harboring a senescence gene: construction of a 4 megabase yeast artificial chromosome contig 137
Nanoparticle-Mediated Delivery of Antisense Oligoribonucleotides Allows Restoration of Dystrophin Expression in the mdx Mouse 136
Conjugates of oligonucleotides and bile acids and their derivatives for pharmaceutical active molecules delivery 135
null 131
Brody disease: Insights into biochemical features of SERCA1 and identification of a novel mutation 131
Nanoparticle of the core-shell type suitable for delivering therapeutic oligonucleotides to target tissues and the use thereof for the preparation of a medicament for treating duchenne muscular distrophy 130
Nanoparticle of the core-​shell type suitable for delivering therapeutic oligonucleotides to target tissues and the use thereof for the preparation of a medicament for treating duchenne muscular dystrophy 125
Tumor suppressor genes. New perspectives for clinical investigations in cancer 114
Association of CYP1B1 with hypersensitivity induced by Taxane therapy in breast cancer patients. 114
Presence of HHV-8 DNA in semen of immunocompetent HIV-negative individuals from different geographical areas in Italy. 110
Genomic and transcription studies as diagnostic tools for a prenatal detection of X-linked dilated cardiomyopathy due to a dystrophin gene mutation. 110
Nanoparticles are effective vehicles for systemic delivery of 2 ' OMePS antisense oligonucleotides in exon skipping-mediated dystrophin restoration 108
Pre-trial antisense screening of myogenic cells from boys with Duchenne muscular dystrophy and genomic and transcriptomic biomarkers discovery for treatment monitoring 104
null 99
null 94
Dystrophin restoration in skeletal, heart and skin arrector pili smooth muscle of mdx mice by ZM2 NP-AON complexes. 94
null 92
null 90
null 90
Multiple exon skipping and RNA circularisation contribute to the severe phenotypic expression of exon 5 dystrophin deletion. 71
Protection from herpes simplex virus type 1 lethal and latent infections by secreted recombinant glycoprotein B costitutively expressed in human cells with a BK virus episomal vector 65
null 42
Totale 12.444
Categoria #
all - tutte 51.590
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.348
Totale 52.938


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021255 0 0 0 0 0 0 0 0 0 85 130 40
2021/2022751 18 48 90 22 50 27 38 34 27 42 79 276
2022/2023812 73 83 20 112 169 103 40 66 89 8 35 14
2023/2024480 38 66 29 8 33 123 20 38 9 13 8 95
2024/20252.038 44 33 141 87 246 182 113 102 417 163 269 241
2025/20264.739 543 189 389 659 784 356 699 241 410 469 0 0
Totale 12.444